Polymorphism of CYP1A1 gene and susceptibility to childhood acute lymphoblastic leukemia in Egypt

References

• Sinnett D, Krajinovic M, Labuda D. Genetic susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymphoma 2000;38:447–462.
   PubMed Web of Science ®Google Scholar
• Nagai F, Hiyoshi Y, Sugimachi K, et al. Cytochrome P450 (CYP) expression in human myeloblastic and lymphoid cell lines. Biol Pharm Bull 2002;25:383–385.
   PubMed Web of Science ®Google Scholar
• Quiñones L, Lee K, Varela FN, et al. Cancer pharmacogenetics: study of genetically determined variations on cancer susceptibility due to xenobiotic exposure. Rev Med Chil 2006;134:499–515.
   PubMed Web of Science ®Google Scholar
• Tompkins LM, Wallace AD. Mechanisms of cytochrome P450 induction. J Biochem Mol Toxicol 2007;21:176–181.
   PubMed Web of Science ®Google Scholar
• Chang BL, Zheng SL, Isaacs SD, et al. Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk. Int J Cancer 2003;106:375–378.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M. Genetic susceptibility to adverse effects of drugs and environmental Toxicants. The role of the CYP family of enzymes. Mutat Res 2001;482:11–19
   PubMed Web of Science ®Google Scholar
• Dufour C, Svahn J, Bacigalupo A, et al. Genetic polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 and the risk of acquired idiopathic aplastic anemia in Caucasian patients. Haematologica 2005;90:1027–1031.
   PubMed Web of Science ®Google Scholar
• Hung RJ, Boffetta P, Brockmöller J, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis 2003;24:875–882.
   PubMed Web of Science ®Google Scholar
• Olshan AF, Weissler MC, Watson MA, et al. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2000;9:185–191.
   PubMed Web of Science ®Google Scholar
• Takanashi M, Morimoto A, Yagi T, et al. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia. Haematologica 2003;88:1238–1244.
   PubMed Web of Science ®Google Scholar
• Kiyohara C, Shirakawa T, Hopkin JM. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer. Environ Health Prev Med 2002;7:47–59.
   PubMedGoogle Scholar
• Hayashi S, Watanabe J, Nakachi K, et al. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem 1991;110:407–411.
   PubMed Web of Science ®Google Scholar
• Zhuo W, Zhang L, Wang Y, et al. CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects. J Exp Clin Cancer Res 2012;31:62.
   PubMed Web of Science ®Google Scholar
• Economopoulos KP, Sergentanis TN. GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur J Cancer 2010;46:1617–1631.
   PubMed Web of Science ®Google Scholar
• Spurdle AB, Webb PM, Purdie DM, et al. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis 2001;22:67–72.
   PubMed Web of Science ®Google Scholar
• Törüner GA, Akyerli C, Uçar A, et al. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol Arch Toxicol 2001;75:459–464.
   PubMed Web of Science ®Google Scholar
• Ji YN, Wang Q, Suo LJ. CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis. PLoS One 2012;7:e43397.
   PubMed Web of Science ®Google Scholar
• Duarte EC, Ribeiro DC, Gomez MV, et al. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression. Anticancer Res 2008;28:1101–1106.
   PubMed Web of Science ®Google Scholar
• Jang JH, Cotterchio M, Borgida A, et al. Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk. Carcinogenesis 2012;33:818–827.
   PubMed Web of Science ®Google Scholar
• Catsburg C, Joshi AD, Corral R, et al. Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer. Carcinogenesis 2012;33:1352–1359.
   PubMed Web of Science ®Google Scholar
• Justenhoven C. Polymorphisms of phase I and phase II enzymes and breast cancer risk. Front Genet 2012;3:258.
   PubMedGoogle Scholar
• Bolufer P, Barragan E, Collado M, et al. Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 2006;30:1471–1491.
   PubMed Web of Science ®Google Scholar
• Roman E, Lightfoot T, Smith AG, et al. Childhood acute lymphoblastic leukaemia and birthweight: insights from a pooled analysis of case-control data from Germany, the United Kingdom and the United States. Eur J Cancer 2013;49:1437–1447.
   PubMed Web of Science ®Google Scholar
• Whyatt RM, Perera FP. Application of biologic markers to studies of environmental risks in children and the developing fetus. Environ Health Perspect 1995;103(Suppl. 6):105–110.
   PubMed Web of Science ®Google Scholar
• Severson RK, Buckley JD, Woods WG, et al. Cigarette smoking and alcohol consumption by parents of children with acute myeloid leukemia: an analysis within morphological subgroups--a report from the Childrens Cancer Group. Cancer Epidemiol Biomarkers Prev 1993;2:433–439.
   PubMed Web of Science ®Google Scholar
• Daniels JL, Olshan AF, Savitz DA. Pesticides and childhood cancers. Environ Health Perspect 1997;105:1068–1077.
   PubMed Web of Science ®Google Scholar
• Stejskalova L, Pavek P. The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl hydrocarbon receptor (AhR) in the placenta. Curr Pharm Biotechnol 2011;12:715–730.
   PubMed Web of Science ®Google Scholar
• Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin Pharmacokinet 2009;48: 689–723.
   PubMed Web of Science ®Google Scholar
• Lin HJ, Han C-Y, Bernstein DA, et al. Ethnic distribution of the glutathione Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 1994;15:1077–1081.
   PubMed Web of Science ®Google Scholar
• Nelson HH, Wiencke JK, Christiani DC, et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 1995;16:1243–1245.
   PubMed Web of Science ®Google Scholar
• Mrozikiewicz PM, Cascorbi I, Brockmöller J, et al. CYP1A1 mutations 4887A, 4889G, 5639C and 6235C in the Polish population and their allelic linkage, determined by peptide nucleic acid-mediated PCR clamping. Pharmacogenetics 1997;7:303–307.
   PubMedGoogle Scholar
• Zhuo W, Zhang L, Qiu Z, et al. Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk?Evidence from2013 cases and 2903 controls. Gene 2012;510:14–21.
   Google Scholar
• D’Alò F, Voso MT, Guidi F, et al. Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia. Haematologica 2004;89:664–670.
   PubMed Web of Science ®Google Scholar
• Balta G, Yuksek N, Ozyurek E, et al. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia. Am J Hematol 2003;73:154–160.
   PubMed Web of Science ®Google Scholar
• Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control population. Cancer Epidemiol Biomark Prev 2001;10:1239–1248.
   PubMed Web of Science ®Google Scholar
• Pakakasama S, Mukda E, Sasanakul W, et al. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia. Am J Hematol 2005;79:202–205.
   PubMed Web of Science ®Google Scholar
• Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, et al. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. Am J Hematol 2006;81:162–170.
   PubMed Web of Science ®Google Scholar
• Suneetha KJ, Nancy KN, Rajalekshmy KR, et al. Role of glutathione-s-transferase and CYP1A1*2A polymorphisms in the therapy outcome of south Indian acute lymphoblastic leukemia patients. Indian J Med Paediatr Oncol 2011;32:25–29.
   PubMedGoogle Scholar
• Bolufer P, Collado M, Barragán E, et al. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica 2007;92:308–314.
   PubMed Web of Science ®Google Scholar
• Clavel J, Bellec S, Rebouissou S, et al. Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Eur J Cancer Prev 2005;14:531–540.
   PubMed Web of Science ®Google Scholar
• Lee KM, Ward MH, Han S, et al. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leuk Res 2009;33:250–258.
   PubMed Web of Science ®Google Scholar
• Joseph T, Kusumakumary P, Chacko P, et al. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children. Pediatr Blood Cancer 2004;43:560–567.
   PubMed Web of Science ®Google Scholar
• Gallegos-Arreola MP, González-García JR, Figuera LE, et al. Distribution of CYP1A1*2A polymorphism in adult patients with acute lymphoblastic leukemia in a Mexican population. Blood Cells Mol Dis 2008;41:91–94.
   PubMed Web of Science ®Google Scholar
• Krajinovic M, Labuda D, Richer C, et al. Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 1999;93:1496–1501.
   PubMed Web of Science ®Google Scholar
• Canalle R, Burim RV, Tone LG, et al. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ Mol Mutagen 2004;43:100–109.
   PubMed Web of Science ®Google Scholar
• Swinney RM, Beuten J, Collier AB 3rd, et al. Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children. Cancer Epidemiol Biomarkers Prev 2011;20: 1537–1542.
   PubMed Web of Science ®Google Scholar
• Infante-Rivard C, Krajinovic M, Labuda D, et al. Parental smoking, CYP1A1 genetic polymorphisms and childhood leukemia (Québec, Canada). Cancer Causes Control 2000;11:547–553.
   PubMed Web of Science ®Google Scholar
• Krajinovic M, Ghadirian P, Richer C, et al. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-enviroment interactions. Int J Cancer 2001;92:220–225.
   PubMed Web of Science ®Google Scholar
• Mourad H, Ahmed A, Sheriff E. Polymorphisms of CYP1A1*4 and GST as susceptibility and prognostic genes for acute myeloid leukemia. Int Med J Malaysia 2010;9:27–35.
   Google Scholar
• Cavalieri EL, Rogan EG. A unified mechanism in the initiation of cancer. Ann NY Acad Sci USA 2002;959:341–354.
   PubMed Web of Science ®Google Scholar
• Chessells JM, Richards SM, Bailey CC, et al. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials. Br J Haematol 1995;89:364–372.
   PubMed Web of Science ®Google Scholar
• Sandler DP, Ross JA. Epidemiology of acute leukemia in children and adults. Semin Oncol 1997;24:3–16.
   PubMed Web of Science ®Google Scholar
• Sugimoto H, Shiro Y. Diversity and substrate specificity in the structures of steroidogenic cytochrome P450 enzymes. Biol Pharm Bull 2012;35:818–823.
   PubMed Web of Science ®Google Scholar
• Mossuz P, Cousin F, Castinel A, et al. Effects of two sex steroids (17 beta estradiol and testosterone) on proliferation and clonal growth of the human monoblastic leukemia cell line, U937. Leuk Res 1998;22:1063–1072.
   PubMed Web of Science ®Google Scholar
• Shuster JJ, Wacker P, Pullen J, et al. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol. 1998;16:2854–2863.
   PubMed Web of Science ®Google Scholar